The NewsBritain’s National Health Service announced on Friday that it would limit the use of puberty-suppressing drugs to children enrolled in clinical trials. The change comes as the agency’s pediatric gender services have struggled to keep up with soaring demand.A document explaining the N.H.S.’s reasoning stated that “there is not enough evidence to support their…
